B. Metzler Seel. Sohn & Co. Holding Ag Glaukos Corp Transaction History
B. Metzler Seel. Sohn & Co. Holding Ag
- $10.1 Trillion
- Q3 2024
A detailed history of B. Metzler Seel. Sohn & Co. Holding Ag transactions in Glaukos Corp stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Holding Ag holds 10,339 shares of GKOS stock, worth $1.48 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,339Holding current value
$1.48 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
312Shares Held
46.9MCall Options Held
75.3KPut Options Held
157K-
Black Rock Inc. New York, NY8.04MShares$1.15 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.45MShares$780 Million0.01% of portfolio
-
State Street Corp Boston, MA1.86MShares$266 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.63MShares$234 Million4.67% of portfolio
-
Janus Henderson Group PLC London, X01.46MShares$208 Million0.09% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.81B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...